Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules

Cancer
Kenneth V RolstonR S Benjamin

Abstract

The objective of this study was to assess the feasibility of empiric, oral, outpatient quinolone monotherapy in 40 adult patients with fever and neutropenia who were at low risk for serious medical complications. Patients with breast cancer or sarcoma who presented with fever and neutropenia and were identified as low risk received empiric, oral, quinolone monotherapy (gatifloxacin at a dose of 400 mg once daily). Patients who had a significant source/focus of infection on presentation were excluded. After an initial observation period of 4 to 8 hours in the emergency center, the remainder of their management was ambulatory. Patients were evaluated for response to therapy, development of complications and/or the need for hospital admission, and drug-related adverse events. Three of 43 patients studied were ineligible medically because of the presence of Common Toxicity Criteria (version 3.0) Grade>2 mucositis. Of the 40 eligible patients, 38 patients (95%) responded to gatifloxacin monotherapy, although 1 patient requested hospital admission (92% response for ambulatory management). The mean duration of therapy was 7 days, and the median number of days from enrollment to defervescence was 4 days. There were no serious medical c...Continue Reading

References

Feb 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A TalcottL Goldman
Nov 1, 1994·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·E B Rubenstein, K Rolston
Jan 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J A TalcottR Finberg
May 6, 1993·The New England Journal of Medicine·P A Pizzo
Oct 26, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K V Rolston
Aug 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J KlasterskyJ Talcott
Feb 19, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Walter T HughesLowell S Young
Dec 10, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ronald FeldUNKNOWN Multinational Association for Supportive Care in Cancer
Sep 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·María E SantolayaMarcela Zubieta
Jun 7, 2005·Cancer·Mallika KamanaKenneth V I Rolston
Sep 1, 2004·Journal of the National Comprehensive Cancer Network : JNCCN·Alison G FreifeldUNKNOWN National Comprehensive Cancer Network

❮ Previous
Next ❯

Citations

Oct 19, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Alison FreifeldJunfeng Sun
Nov 5, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Catherine D CooksleyLinda S Elting
Apr 24, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kenneth V I RolstonRobert S Benjamin
Nov 4, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S SchelenzS Abdallah
Oct 24, 2009·Emergency Medicine Journal : EMJ·J M Moon, B J Chun
Mar 4, 2008·Internal Medicine·Kenichi NomuraMasafumi Taniwaki
Jan 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of Americaa
Jan 25, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of America
Jun 12, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Nina LathiaNicole Mittmann
Jun 5, 2007·Current Opinion in Oncology·Helen Innes, Ernie Marshall
Jan 27, 2007·Pediatric Blood & Cancer·Antoniosérgio PetrilliCarlos Alberto Pires Pereira
Jan 29, 2011·Internal Medicine Journal·L J WorthUNKNOWN Australian Consensus Guidelines 2011 Steering Committee
Jan 29, 2011·Internal Medicine Journal·C S TamUNKNOWN Australian Consensus Guidelines 2011 Steering Committee
Jan 12, 2013·Pharmacotherapy·Frank P TverdekRoy F Chemaly
Feb 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Linda S EltingKenneth Rolston
Jun 6, 2007·Expert Review of Anti-infective Therapy·Mickael Aoun
Mar 27, 2007·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Kevin G Moores
Oct 10, 2013·The Cochrane Database of Systematic Reviews·Liat VidalLeonard Leibovici
Aug 12, 2020·Journal of Clinical and Experimental Hematopathology : JCEH·Ai MogiYasushi Takamatsu
Jun 2, 2020·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Meghan J ElliottPaul E Ronksley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.